Scientific Sessions 2024  /  Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease  /  Precision-Based Small Molecule Therapeutics
Logo

American Heart Association

  106
  0

Final ID:

Precision-Based Small Molecule Therapeutics

  • Ho, Carolyn  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Ahmad, Ferhaan  ( UNIVERSITY OF IOWA , Iowa City , Iowa , United States )
    • Author Disclosures:
    Carolyn Ho: DO have relevant financial relationships ; Consultant:Bristol Myers Squib:Active (exists now) ; Consultant:viz.ai:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) | Ferhaan Ahmad: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Past (completed) ; Research Funding (PI or named investigator):Solid Biosciences:Active (exists now) ; Consultant:Cytokinetics:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Leveraging GWAS to Identify Novel Drug Targets

Bouatia-naji Nabila, Ganesh Santhi

Gene Therapy for Rare Cardiovascular Diseases

Mcnally Elizabeth, Bursac Nenad

More abstracts from these authors:
Hypertrophic Cardiomyopathy: Does Genotype Matter?

Ho Carolyn, Parikh Victoria, Raymer David, Sailer Christine

Sex as a modifier of outcomes in genetic cardiomyopathies

Tayal Paz, Ho Carolyn

You have to be authorized to contact abstract author. Please, Login
Not Available